Media-OutReach Newswire The United Laboratories International Holdings Limited Applies for the Clinical Trial of its Class 1 Innovative New Drug UBT251 Injection
Politics & Laws Ringleaders in fatal attacks in Đắk Lắk arrested, ethnic tension motive investigated: Police